Research Article
[Retracted] Alterations of Several Serum Parameters Are Associated with Preeclampsia and May Be Potential Markers for the Assessment of PE Severity
Table 2
Serum markers’ values in different groups.
| Marker | Control | mPE | sPE | Control vs. mPE | Control vs. sPE | mPE vs. sPE |
| ALB | 38 (37-42) | 31.5 (25.5-34.5) | 28.5 (24-33) | <0.001 | <0.001 | 0.2113 | TP | 65 (63-68.25) | 56.5 (52-61) | 51.5 (49-58) | 0.0002 | <0.001 | 0.4046 | PA | | | | 0.0002 | <0.001 | 0.0555 | ALP | 66 (52.5-76.5) | 168 (141.5-201.25) | 182.5 (120-191.5) | 0.0009 | 0.0001 | 0.4291 | LDH | 152 (139.75-166.25) | 183.5 (163.25-307) | 282 (215.25-306) | 0.0022 | <0.001 | 0.0444 | D-dimer | 1.05 (0.65-1.57) | 3.05 (2.25-4.08) | 5.65 (2.29-7.71) | <0.001 | <0.001 | 0.0115 | Fbg | | | | 0.3969 | 0.0484 | 0.0470 | PLT | 232 (197-252.25) | 211 (178-279) | 169 (158-191.25) | 0.4932 | <0.001 | 0.0066 | MPV | | | | 0.2419 | 0.0137 | 0.1031 | PDW | | | | 0.1365 | 0.3810 | 0.2640 |
|
|
Data are presented as when the parameters’ distributions were normal distribution or median and interquartile ranges when skewed. |